Praxis Precision Stock Forward View - Simple Moving Average
| PRAX Stock | USD 305.00 11.05 3.76% |
Momentum
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter -3.55 | EPS Estimate Current Year -15.22 | EPS Estimate Next Year -8.65 | Wall Street Target Price 600.7059 | EPS Estimate Current Quarter -3.13 |
This section provides headline-driven context for Praxis Precision Medicines alongside peer activity. The sentiment layer reflects Praxis Precision's options activity and short interest context.
Short Interest Detail for Praxis Precision
A significant increase or decrease in Praxis Precision's short interest from the previous month could be a good indicator of investor sentiment towards Praxis. Short interest can provide insight into the potential direction of Praxis Precision stock and how bullish or bearish investors.
200 Day MA 156.4242 | Short Percent 0.1361 | Short Ratio 8.02 | Shares Short Prior Month 3.8 M | 50 Day MA 311.6012 |
Praxis RSI Snapshot
The Simple Moving Average forecasted value of Praxis Precision Medicines on the next trading day is expected to be 305.00 with a mean absolute deviation of 7.89 and the sum of the absolute errors of 465.78.Praxis Precision Hype-Price Relationship
Investor biases related to Praxis Precision's public news can be used to forecast risks associated with an investment in Praxis. The trend in average sentiment can be used to explain how an investor holding Praxis can time the market purely based on public headlines and social.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Praxis Precision's market sentiment to its price can help traders make decisions based on the overall investor consensus about Praxis Precision.
Praxis Precision Implied Volatility | 1.14 |
Praxis Precision's implied volatility exposes the market's sentiment of Praxis Precision Medicines stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Praxis Precision's implied volatility is high, the market thinks the stock has potential.
The Simple Moving Average forecasted value of Praxis Precision Medicines on the next trading day is expected to be 305.00 with a mean absolute deviation of 7.89 and the sum of the absolute errors of 465.78.Praxis Precision after-hype prediction price | $ 306.03 |
Hype signals are presented as complementary context to forecasting, technicals, analyst estimates, earnings, and momentum.
Use Historical Fundamental Analysis of Praxis Precision to cross-verify projections for Praxis Precision. The view supplies historical context for the projection discussion.Rule 16 for the current Praxis contract
Rule 16 converts implied volatility into an estimated daily move of about 7.12% for 2026-05-15 options. This estimate is a volatility reference; at $ 305.0, it implies a move of about $ 21.73 per day.
Open Interest for Praxis 2026-05-15 Options
Open interest data captures outstanding Praxis Precision option contracts and helps map participation over time.
Praxis Precision Additional Predictive Modules
Most predictive techniques to examine Praxis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Praxis using various technical indicators. When you analyze Praxis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Simple Moving Average Price Forecast For the 17th of March 2026
Given 90 days horizon, the Simple Moving Average forecasted value of Praxis Precision Medicines on the next trading day is expected to be 305.00 with a mean absolute deviation of 7.89 , mean absolute percentage error of 98.89 , and the sum of the absolute errors of 465.78 .Please note that although there have been many attempts to predict Praxis Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Praxis Precision's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Praxis Precision | Praxis Precision Price Prediction | Research Analysis |
Forecasted Value
The next-day forecast for Praxis Precision Medicines focuses on identifying predictive downside and upside bands that can frame a realistic trading range. Used properly, these levels provide context around forecast dispersion rather than certainty about the next closing print.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Praxis Precision stock data series using in forecasting. Note that when a statistical model is used to represent Praxis Precision stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 119.0288 |
| Bias | Arithmetic mean of the errors | -0.9375 |
| MAD | Mean absolute deviation | 7.8946 |
| MAPE | Mean absolute percentage error | 0.0259 |
| SAE | Sum of the absolute errors | 465.78 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Praxis Precision's price to converge to an average value over time is called mean reversion.
After-Hype Price Density Analysis
As far as predicting the price of Praxis Precision at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
In the context of predicting Praxis Precision's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Praxis Precision's historical news coverage.
Current Value
The after-hype framework applied to Praxis Precision Medicines assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Praxis Precision is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Praxis Precision backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Praxis Precision, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.22 | 3.34 | 0.61 | 0.14 | 9 Events | 7 Events | In 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
305.00 | 306.03 | 0.21 |
|
Hype Timeline
Praxis Precision is at this time traded for 305.00. The company has historical hype elasticity of 0.61, and average elasticity to hype of competition of 0.14. Praxis is forecasted to increase in value after the next headline, with the price projected to jump to 306.03 or above. The average volatility of media hype impact on the company the price is about 121.01%. The price jump on the next news is projected to be 0.21%, whereas the daily expected return is at this time at 0.22%. The volatility of related hype on Praxis Precision is about 532.7%, with the expected price after the next announcement by competition of 305.14. Net Loss for the year was -303.27 M with loss before overhead, payroll, taxes, and interest of -267.12 M. Given the investment horizon of 90 days the next forecasted press release will be in 9 days. Use Historical Fundamental Analysis of Praxis Precision to cross-verify projections for Praxis Precision. The view supplies historical context for the projection discussion.Related Hype Analysis
Having access to credible news sources related to Praxis Precision's direct competition is more important than ever and may enhance your ability to predict Praxis Precision's future price movements. Getting to know how Praxis Precision's peers react to changing market sentiment, related social.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CRNX | Crinetics Pharmaceuticals | 0.42 | 8 per month | 0.00 | -0.08 | 3.48 | -5.35 | 23.50 | |
| SLNO | Soleno Therapeutics | 0.43 | 8 per month | 0.00 | -0.17 | 4.72 | -5.92 | 16.87 | |
| VKTX | Viking Therapeutics | 0.02 | 9 per month | 0.00 | 0.0035 | 6.80 | -5.49 | 22.96 | |
| KYMR | Kymera Therapeutics | -0.79 | 10 per month | 0.00 | -0.07 | 4.40 | -4.93 | 11.97 | |
| ACAD | ACADIA Pharmaceuticals | 0.16 | 7 per month | 0.00 | -0.15 | 3.96 | -3.83 | 12.00 | |
| LGND | Ligand Pharmaceuticals Incorporated | 4.10 | 10 per month | 2.21 | 0.09 | 3.29 | -3.35 | 12.22 | |
| XENE | Xenon Pharmaceuticals | 2.20 | 8 per month | 1.97 | 0.08 | 3.78 | -3.43 | 53.07 | |
| AKRO | Akero Therapeutics | -0.25 | 4 per month | 0.63 | 0.14 | 3.29 | -2.12 | 16.73 | |
| CNTA | Centessa Pharmaceuticals PLC | -0.45 | 9 per month | 0.00 | -0.04 | 4.04 | -3.54 | 11.95 | |
| IMVT | Immunovant | 0.43 | 9 per month | 2.20 | 0.05 | 4.47 | -3.63 | 16.18 |
Other Forecasting Options for Praxis Precision
For every potential investor in Praxis, whether a beginner or expert, Praxis Precision's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better.Praxis Precision Related Equities
The following equities are related to Praxis Precision within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Praxis Precision against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Praxis Precision Market Strength Events
Market strength indicators help investors to evaluate how Praxis Precision stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Praxis Precision shares will generate the highest return on.
Praxis Precision Risk Indicators
The analysis of Praxis Precision's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Praxis Precision's investment and either accepting that risk or mitigating it.
| Mean Deviation | 2.4 | |||
| Semi Deviation | 2.69 | |||
| Standard Deviation | 3.3 | |||
| Variance | 10.86 | |||
| Downside Variance | 8.18 | |||
| Semi Variance | 7.26 | |||
| Expected Short fall | -2.50 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Praxis Precision
Story coverage around Praxis Precision Medicines often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Contributor Headline
Latest Perspective From Macroaxis
Praxis Precision Short Properties
A short-interest review of Praxis Precision Medicines helps investors understand whether skepticism in the market is becoming more influential. A disciplined short-interest review can make timing decisions more informed under rising skepticism.
| Common Stock Shares Outstanding | 22.5 M | |
| Cash And Short Term Investments | 599.3 M |
More Resources for Praxis Stock Analysis
Reviewing Praxis Precision commonly begins with financial statements and performance trends. Financial ratios provide a structured lens for assessing Praxis Precision's profitability and growth trends. Below are reports that help frame Praxis Precision Medicines Stock in context:Use Historical Fundamental Analysis of Praxis Precision to cross-verify projections for Praxis Precision. The view supplies historical context for the projection discussion. Praxis Precision currently shows ROE of -45.83%, market cap of 8.19 Billion. This analysis of Praxis Precision works best as a complementary layer when evaluating how the security fits in a broader portfolio. The supplemental views below help investors decide how Praxis Precision complements or overlaps with existing portfolio holdings. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Earnings Share -13.49 | Revenue Per Share | Quarterly Revenue Growth 13.491 | Return On Assets | Return On Equity |
Investors evaluate Praxis Precision using market value and book value, each describing different facets of the business. Praxis Precision's market capitalization is 8.19 B. With a P/B ratio of 9.32, the market values Praxis Precision well above its book equity. Enterprise value stands at 7.59 B. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
The concept of value for Praxis Precision differs from its quoted price, since each reflects a different lens. For Praxis Precision, key inputs include a P/B ratio of 9.32, and ROE of -45.83%. Praxis Precision's market quotation reflects the latest level where a willing buyer met a willing seller.